A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

NCT00770341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infection

Interventions

DRUG: Daptomycin 4 mg/kg
DRUG: Comparator: vancomycin
DRUG: Daptomycin 6 mg/kg

Sponsor

Merck Sharp & Dohme LLC